News Releases Year: All News20182017201620152014201320122011 Items per page All News2550 August 7, 2018 Summary ToggleAllena Pharmaceuticals to Present at 2018 Wedbush PacGrow Healthcare Conference Read more August 7, 2018 Summary ToggleAllena Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Business Update Read more July 23, 2018 Summary ToggleAllena Pharmaceuticals Announces First Patients Treated in Phase 2 Basket Study of ALLN-177 in Patients with Primary Hyperoxaluria or Enteric Hyperoxaluria and Advanced Chronic Kidney Disease Read more June 19, 2018 Summary ToggleAllena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease Read more June 11, 2018 Summary ToggleAllena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors Read more May 30, 2018 Summary ToggleAllena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference Read more May 8, 2018 Summary ToggleAllena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update Read more March 27, 2018 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Read more March 7, 2018 Summary ToggleAllena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference Read more March 6, 2018 Summary ToggleAllena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria Read more Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next Last page Last
